Company: LGN
Filing Date: 2025-05-14
Form Type: DRS/A
Source: 0000950123-25-005247
Chunk: 99

Company: Legence Corp.
Filing Date: 2025-05-14
Form: DRS/A
Chunk 99
---
 Stock offered by us based upon the assumed public offering price of
$ per share of Class A Common Stock (the midpoint of the price range set forth on the cover page of this prospectus), after deducting underwriting discounts and commissions and estimated offering expenses payable by
us.

We intend to contribute all of the net proceeds from this offering (not including the exercise of the underwriters’ option to
purchase additional shares) to Legence Holdings in exchange for LGN Units. Legence Holdings intends to use such net proceeds from this offering for the repayment of outstanding borrowings under our Term Loan Credit Facility and the remaining
proceeds for general corporate purposes.

To the extent the underwriters exercise their option to purchase up
to additional shares of Class A Common Stock from us and additional shares of Class A Common Stock from the selling stockholder, we intend to contribute the net proceeds received from the sale of
additional shares by us to Legence Holdings in exchange for additional LGN Units being issued to Legence Sub, and Legence Holdings will use such net proceeds to purchase LGN Units, together with an equal number of shares of Class B Common
Stock, from Aggregator I at a purchase price per LGN Unit and share of Class B Common Stock equal to the public offering price per share of Class A Common Stock in this offering, net of underwriting discounts and commissions.

We will not receive any proceeds from the sale of additional shares of Class A Common Stock by the selling stockholder. We will, however, bear
the costs associated with the sale of additional shares of Class A Common Stock by the selling stockholder, other than underwriting discounts and commissions. For more information, see “Principal and Selling Stockholders” and
“Underwriting.”

As of December 31, 2024, we had an outstanding principal balance of approximately $1,590.4 million under
the Term Loan Credit Facility. The Term Loan Credit Facility matures on December 16, 2028. Legence Holdings can elect for borrowings of term loans (including delayed draw term loans) to be classified as either SOFR loans or base rate loans.
SOFR loans bear interest at a rate equal to SOFR plus a margin of either 2.75%, 3.00% or 3.25%, which margin is determined based on the Company’s most recently reported Consolidated First Lien Net Leverage Ratio (the “First Lien Net
Leverage Ratio”), generally defined as the ratio of first lien secured indebtedness (